Cheng Wei

669 total citations
18 papers, 387 citations indexed

About

Cheng Wei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng Wei has authored 18 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng Wei's work include Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (3 papers). Cheng Wei is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (3 papers). Cheng Wei collaborates with scholars based in China and United States. Cheng Wei's co-authors include Lei Han, Hao Liang, Xiaoyang Zhang, Lin Luo, Zhenyu Zhang, Shenghui Li, Xiaoyang Zhang, Yingwei Zhen, Ze‐Sheng Li and Yingjie He and has published in prestigious journals such as Hepatology, Frontiers in Immunology and Nutrients.

In The Last Decade

Cheng Wei

17 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng Wei China	11	296	208	53	50	45	18	387
Junyi Ju China	12	441 1.5×	217 1.0×	72 1.4×	53 1.1×	95 2.1×	15	578
Ai‐Yan Xing China	11	373 1.3×	282 1.4×	38 0.7×	39 0.8×	80 1.8×	24	482
Xianting Huang China	12	241 0.8×	85 0.4×	54 1.0×	42 0.8×	89 2.0×	28	370
Yaoyun Tang China	9	329 1.1×	178 0.9×	44 0.8×	42 0.8×	75 1.7×	13	426
Liyun Luo China	11	428 1.4×	348 1.7×	46 0.9×	28 0.6×	80 1.8×	17	529
Nicole P. Ho Hong Kong	6	265 0.9×	213 1.0×	46 0.9×	41 0.8×	137 3.0×	9	453
Singer Ma United States	5	321 1.1×	184 0.9×	58 1.1×	18 0.4×	84 1.9×	6	415
Laura Pisarsky Switzerland	6	259 0.9×	216 1.0×	63 1.2×	30 0.6×	142 3.2×	8	403
Kalle Ojala Finland	6	236 0.8×	76 0.4×	38 0.7×	48 1.0×	85 1.9×	12	334
Verónica Moncho-Amor Spain	8	263 0.9×	128 0.6×	35 0.7×	22 0.4×	96 2.1×	15	366

Countries citing papers authored by Cheng Wei

Since Specialization

Citations

This map shows the geographic impact of Cheng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Wei more than expected).

Fields of papers citing papers by Cheng Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Wei. The network helps show where Cheng Wei may publish in the future.

Co-authorship network of co-authors of Cheng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Wei. A scholar is included among the top collaborators of Cheng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Wei. Cheng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Xilei, Yalong Gao, Lei Li, et al.. (2025). Glioblastoma Cells Express and Secrete Alternatively Spliced Transcripts of Coagulation Factor X. Biomedicines. 13(3). 576–576.

Yu, Runze, Cheng Wei, Bo Wang, et al.. (2025). USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. Cell Death and Disease. 16(1). 449–449. 1 indexed citations

Ma, Yana, Jingjing Qian, Xin Xu, et al.. (2024). Engraftment of self-renewing endometrial epithelial organoids promotes endometrial regeneration by differentiating into functional glands in rats. Frontiers in Bioengineering and Biotechnology. 12. 1449955–1449955. 1 indexed citations

Wang, Xianli, Zening Wang, Cheng Wei, et al.. (2024). Multi-Omics Profiles of Small Intestine Organoids in Reaction to Breast Milk and Different Infant Formula Preparations. Nutrients. 16(17). 2951–2951. 1 indexed citations

Wei, Cheng, Bo Wang, Ze‐Sheng Li, et al.. (2024). A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ. Cellular & Molecular Biology Letters. 29(1). 127–127. 4 indexed citations

Xu, Jianye, Cheng Wei, Cong Wang, et al.. (2024). TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 167041–167041. 8 indexed citations

Luo, Lin, Yingwei Zhen, Cheng Wei, et al.. (2022). The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. Cell Death Discovery. 8(1). 325–325. 15 indexed citations

Zhang, Xiaoyang, Ze-Sheng Li, Cheng Wei, et al.. (2022). PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas. Frontiers in Oncology. 12. 1055371–1055371. 10 indexed citations

Luo, Lin, et al.. (2022). CircRNA: An emerging star in the progression of glioma. Biomedicine & Pharmacotherapy. 151. 113150–113150. 28 indexed citations

10.

Wei, Cheng, Bo Wang, Xiaoyang Zhang, et al.. (2022). Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. Frontiers in Immunology. 13. 849592–849592. 73 indexed citations

11.

Luo, Lin, Xiaoyang Zhang, Yingwei Zhen, et al.. (2022). Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. Frontiers in Immunology. 13. 1058036–1058036. 5 indexed citations

12.

Wei, Cheng, Xiaoyang Zhang, Xu Zhang, et al.. (2022). LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway. Cell Death and Disease. 13(11). 942–942. 23 indexed citations

13.

Zhang, Yang, Cheng Wei, Biao Han, et al.. (2021). Let-7i-5p functions as a putative osteogenic differentiation promoter by targeting CKIP-1. Cytotechnology. 73(1). 79–90. 10 indexed citations

14.

Zhang, Xiaoyang, Cheng Wei, Hao Liang, & Lei Han. (2021). Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy. Frontiers in Oncology. 11. 587554–587554. 42 indexed citations

15.

Wei, Cheng, Xiaoyang Zhang, Shenghui Li, et al.. (2021). Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers. Cancer Cell International. 21(1). 566–566. 24 indexed citations

16.

Wei, Cheng, et al.. (2020). Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review). Oncology Reports. 43(6). 1737–1754. 22 indexed citations

17.

Ma, Meilin, Haixia Xu, Geng Liu, et al.. (2019). Metabolism‐induced tumor activator 1 (MITA1), an Energy Stress–Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis. Hepatology. 70(1). 215–230. 73 indexed citations

18.

Wang, Zengguang, Kai Huang, Yanwei Liu, et al.. (2018). PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma. Cancer Letters. 443. 91–107. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact